First‐in‐human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumors

TAS0313, a novel cancer vaccine cocktail, was developed to overcome the disadvantages of previously developed short and long peptide vaccines; it comprises several long peptides targeting multiple cancer antigens. We evaluated TAS0313 monotherapy in Japanese patients with advanced solid tumors for w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Kondo, Shunsuke, Shimizu, Toshio, Koyama, Takafumi, Sato, Jun, Iwasa, Satoru, Yonemori, Kan, Fujiwara, Yutaka, Shimomura, Akihiko, Kitano, Shigehisa, Tamura, Kenji, Yamamoto, Noboru
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
ORIGINAL ARTICLES
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8019195/
https://ncbi.nlm.nih.gov/pubmed/33615628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14765
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars